Approved label populations may be broader than trial populations for new drugs
1. In this cross-sectional study, approved label populations were broader overall compared to trial populations for new drugs in the ...
1. In this cross-sectional study, approved label populations were broader overall compared to trial populations for new drugs in the ...
1. In this systematic review, patients with episodic migraine preferred oral pharmacologic treatments that reduced the severity, frequency, and duration ...
1. In a retrospective cohort study, the use of alpha-2-adrenergic agonists to treat attention-deficit hyperactivity disorder (ADHD) in preschool children was ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.